GlassScriptPhysician profile
Jessica Perry Lukowski
NPI 1558556258
$1,202.81
in general payments reported to CMS, 2019-2025
25 companies · $24.72 in 2025
The $24.72 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $487 · 2020: $91.78 · 2021: $40.82 · 2022: $121 · 2023: $222 · 2024: $216 · 2025: $24.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $462.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $288.64 | 2019-2023 | |
| Daiichi Sankyo INC. | $187.82 | 2019-2023 | Injectafer |
| Optumhealth Care Solutions, LLC | $150.11 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Bayer Healthcare Pharmaceuticals INC. | $54.92 | 2020-2023 | |
| Amag Pharmaceuticals, INC. | $50.70 | 2019-2020 | |
| Amgen INC. | $47.31 | 2019-2020 | |
| Davol INC. | $46.37 | 2022 | |
| Exeltis, USA INC. | $42.02 | 2023-2024 | Slynd |
| Organon LLC | $32.93 | 2024 | |
| Duchesnay USA Incorporated | $31.17 | 2019 | |
| Astellas Pharma US INC | $28.64 | 2023-2024 | Veozah |
| Merck Sharp & Dohme LLC | $25.89 | 2019 | |
| Boston Scientific Corporation | $24.72 | 2025 | Wavewriter Alpha Prime 16 |
| Sanara Medtech INC. | $23.07 | 2023 | Celleraterx |
| Novo Nordisk INC | $23.04 | 2023 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.22 | 2019 | |
| Hologic Sales and Service, LLC | $16.56 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.52 | 2022 | |
| Meditrina | $16.17 | 2023 | |
| Axonics, INC. | $14.99 | 2023 | Axonics |
| Pfizer INC. | $14.40 | 2019 | |
| Therapeuticsmd, INC. | $13.21 | 2019 | |
| Shire North American Group INC | $13.12 | 2019 | |
| Avion Pharmaceuticals | $12.43 | 2019 | |
| Allergan, INC. | $10.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Lukowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.